September 27, 2016 11:23 AM ET

Capital Markets

Company Overview of The Biotech Growth Trust PLC

Company Overview

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

601 Lexington Avenue

54th Floor

New York, NY 10022

United States

Founded in 1997





Key Executives for The Biotech Growth Trust PLC

Partner and Co-Portfolio Manager
Portfolio Manager
Age: 71
Portfolio Manager
Compensation as of Fiscal Year 2016.

The Biotech Growth Trust PLC Key Developments

The Biotech Growth Trust plc Appoints Julia Le Blan as Non-Executive Director

The Biotech Growth Trust PLC announced that Julia Le Blan has been appointed as a non-executive director of the company with effect from July 12, 2016.

The Biotech Growth Trust PLC Announces Directorate Changes

The Biotech Growth Trust PLC announced that Lord Waldegrave of North Hill has retired as a non-executive Director and Chairman of the company on 12 July 2016. Mr. Andrew Joy has taken over as Chairman of the company with effect from the same date. It is further announced that Professor Dame Kay Davies, CBE, has taken over from Mr. Joy as the company’s Senior Independent Director and also as the Chairman of the Remuneration Committee.

The Biotech Growth Trust PLC, Annual General Meeting, Jul 12, 2016

The Biotech Growth Trust PLC, Annual General Meeting, Jul 12, 2016, at 12:00 GMT Standard Time. Location: at Barber-Surgeons' Hall Monkwell Square, Wood Street London EC2Y 5BL United Kingdom Agenda: To receive and, if thought fit, to accept the audited financial statements and the report of the directors for the year ended 31 March 2016; to approve the Directors' remuneration report for the year ended 31 March 2016; to re-elect Directors of the Company; and to consider to re-appoint Ernst & Young LLP as Auditor to the Company and to authorize the Audit and Management Engagement Committee to determine their remuneration.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Biotech Growth Trust PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at